Cookies and Similar Technologies The Site may use cookies, local storage, pixels, and similar technologies to operate navigation and cart features, remember choices, protect the Site, understand traffic, andif later enabledmeasure campaigns
378 Certain scholars posit that the removal of benzbromarone from the market may not align with the best interests of patients with gout, with the argument that conceivable toxicity could be mitigated through a cautious approach involving gradual dosage escalation coupled with vigilant monitoring of liver function
[DOI] [PubMed] [Google Scholar] 72.Marin-Kuan M., Nestler S., Verguet C., Bezencon C., Piguet D., Mansourian R., Holzwarth J., Grigorov M., Delatour T., Mantle P., et al
111-148) amended section 1833(t) of the Act by adding a new paragraph (18), which instructs the Secretary to conduct a study to determine if, under the OPPS, outpatient costs incurred by cancer hospitals described in section 1886(d)(1)(B)(v) of the Act with respect to APC groups exceed outpatient costs incurred by other hospitals furnishing services under section 1833(t) of the Act, as determined appropriate by the Secretary
